4D Molecular Therapeutics Inc.
4DMT Highlights Robust and Durable Clinical Activity for 4D 150 and[...]
08/26/2022 | Press release | Distributed by Public on 08/26/2022 09:23
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact